Prospective Cohort Study for Evaluating the Safety and Efficacy of Mobile, Motorized Enhanced Extracorporeal Counterpulsation in Patients With Refractory Angina

Enhanced external counterpulsation (EECP) is a noninvasive medical device designed for patients with refractory angina, a condition in which angina symptoms persist despite adequate medical therapy or revascularization.1 Despite its class IIb recommendation for relieving refractory angina symptoms, existing EECP equipment has limited use owing to cost, noise, vibration, and fixed compression power, causing discomfort for patients.1 –3 In addition, its large size and immobility restrict its application for critically ill patients unable to use EECP equipment.
Source: The American Journal of Cardiology - Category: Cardiology Authors: Tags: Brief Report Source Type: research